Similar articles

• Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.

  Stiehl A, Raedsch R, Czygan P, Götz R, Männer C, Walker S, Kommerell B. Stiehl A, et al. Gastroenterology. 1980 Dec;79(6):1192-8. Gastroenterology. 1980. PMID: 7439628
• Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.

  Fromm H. Fromm H. Gastroenterology. 1984 Jul;87(1):229-33. Gastroenterology. 1984. PMID: 6724267 No abstract available.
• Current status of chenodeoxycholic acid (chenodiol) therapy of cholesterol gallstones.

  Zak RA, Marks JW, Schoenfield LJ. Zak RA, et al. Semin Liver Dis. 1983 May;3(2):132-45. doi: 10.1055/s-2008-1040679. Semin Liver Dis. 1983. PMID: 6408740 Review. No abstract available.
• Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.

  Nilsell K. Nilsell K. Acta Chir Scand Suppl. 1985;528:1-38. Acta Chir Scand Suppl. 1985. PMID: 3866449 No abstract available.
• [Medical treatment of gallstones (author's transl)].

  Gérolami A, Montet JC, Marteau C, Reynier MO, Crotte C. Gérolami A, et al. Gastroenterol Clin Biol. 1980;4(8-9):588-99. Gastroenterol Clin Biol. 1980. PMID: 7000610 Review. French. No abstract available.